Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3851383

CN(c1cccc(N2CCN(c3ncnc4ccc(-c5cn[nH]c5)cc34)CC2)c1)S(=O)(=O)c1ccccc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.46
CYP3A4 P08684 10/20 0.40
CLK4 Q9HAZ1 9/20 0.40
HIF1A Q16665 5/20 0.40
USP2 O75604 6/20 0.40
HSD17B10 Q99714 4/20 0.40
TSHR P16473 3/20 0.40
HTR1A P08908 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR7 P34969 1/20 0.40
DRD3 P35462 1/20 0.40
HTR6 P50406 1/20 0.40
HPGD P15428 2/20 0.39
CYP1A2 P05177 8/20 0.39
MAPK1 P28482 6/20 0.39
LMNA P02545 5/20 0.39
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3853337 0.93 AKT1 (0.48) AKT1CYP3A4CLK4HIF1AUSP2
Trifluoroacetic Acid SCHEMBL3847446 0.87 AKT1 (0.49) AKT1CYP3A4CLK4HIF1AUSP2
Trifluoroacetic Acid SCHEMBL3857438 0.86 AKT1 (0.47) AKT1CYP3A4CLK4HIF1AUSP2
Trifluoroacetic Acid SCHEMBL3851634 0.86 AKT1 (0.48) AKT1CYP3A4CLK4HIF1AUSP2
Trifluoroacetic Acid SCHEMBL3850108 0.86 AKT1 (0.51) AKT1CYP3A4CLK4HIF1AUSP2
Trifluoroacetic Acid SCHEMBL3849296 0.85 AKT1 (0.47) AKT1CYP3A4CLK4HIF1AUSP2
Trifluoroacetic Acid SCHEMBL3847772 0.85 AKT1 (0.48) AKT1CYP3A4CLK4HIF1AUSP2
Trifluoroacetic Acid SCHEMBL3847451 0.85 AKT1 (0.49) AKT1CYP3A4CLK4HIF1AUSP2
Trifluoroacetic Acid SCHEMBL3851786 0.85 AKT1 (0.49) AKT1CYP3A4CLK4HIF1AUSP2
Trifluoroacetic Acid SCHEMBL3849091 0.84 CYP3A4 (0.47) AKT1CYP3A4CLK4HIF1AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed